Group items tagged

Vibrio Parahaemolyticus - Genomic DNA was isolated from the pure culture pellet provided by Medical Research Centre- (Mumbai), on behalf of Mahendra Trivedi.

ACL Digital Life Sciences has a track record of partnering successfully with some of the leading Pharmaceuticals, Biotechs, CROs, Medical Devices and MSP companies. We offer multiple sourcing models to suit your business needs. We work with an MSP of your choice, insourcing staff augmentation, insourcing and outsourcing FSP models and Project-based deliverables. We do this to provide you with the flexibility you need - whether it's for onsite or remote resources, long term or project-specific resources, SME consultation, resources available across multiple geographic areas, resources mapping US time zones or working off-hours in local time zones, among other requirements.

Developing a sound regulatory strategy, in-depth understanding of the country or region-specific regulatory requirements for specific product categories, along with accurate interpretations, implications, and applicability of such regulations, are instrumental in achieving a global outreach for medical products. Whether the product is a medical device, diagnostics, biologics, or a pharmaceutical drug, a careful consideration of the regulatory strategy early on is crucial for securing timely clearances or approvals.

"People swap bacteria all the time-through sneezes and coughs, through hugs and sex, or through touching the same surfaces. Then there are people who swap bacteria because a doctor deliberately transplants faeces from one into the other. This isn't a bizarre medical perversion. It's usually a life-saving gambit. Faecal transplants-which are exactly what they sound like-are used to treat people who suffer from intense diarrhoea following rounds of antibiotics. The goal is simple: recalibrate the beneficial bacteria in a person's gut to fight off the ones that are causing them harm."

"A new bioprinter developed at a hackerspace can print living cells for less than the cost of an iPod touch. 3-D bioprinters have the potential to change the way medical research is conducted, even print living tissue and replacement organs, but they are expensive and highly specialized. They literally build living structures, like blood vessels or skin tissue, cell by cell, revolutionizing biomedical engineering. Unfortunately, they're expensive, rare, and require a Ph.D. (or two) to operate successfully. Frustrated by their cost and exclusivity, a group of makers at the DIYbio hackerspace BioCurious are developing a system open to anyone with a soldering iron and a serious passion for cell biology."

"For 20 years, researchers have reported a potential link between gum disease and atherosclerotic heart disease from hardening of the arteries or stroke. "The message sent out by some in health-care professions, that heart attack and stroke are directly linked to gum disease, can distort the facts, alarm patients and perhaps shift the focus on prevention away from well-known risk factors for these diseases," said Dr. Peter Lockhart, a professor and chair of oral medicine at the Carolinas Medical Center in Charlotte, N.C. Lockhart wrote the heart group's new position statement in the journal Circulation. The statement was prepared after a three-year analysis of about 600 studies by an expert panel led by a dentist and a cardiologist."

A leader in service and learning

"Was die Zellzahl angeht, besteht jeder Mensch zu 90 Prozent aus Mikroben", sagt Dennis Kasper von der Harvard Medical School in Boston. Die Hauptmasse dieser Mitbewohner des menschlichen Körpers lebt im Darm. Sie unterstützen nicht nur die Verdauung, sondern sind für unsere Gesundheit generell unverzichtbar. So wie sie sich speziell an ihren Wirt angepasst haben, hat sich auch unser Organismus an die Mikroben angepasst. Insbesondere hängt die normale Entwicklung des Immunsystems von der Mitwirkung der Darmkeime ab. Das schließen Kasper und seine Kollegen aus ihren Experimenten mit Mäusen, die in keimfreier Umgebung gehalten wurden. In den bakterienfreien Darm neugeborener Mäuse übertrugen die Forscher ein natürliches Gemisch von Darmmikroben, das entweder von gesunden Mäusen oder von gesunden Menschen stammte. In beiden Fällen kam es zum Wachstum von Bakterien in ähnlich hoher Zahl und mit einem ähnlich breiten Artenspektrum. Beide Bakterienpopulationen waren aber aus sehr unterschiedlichen Keimspezies zusammengesetzt, wie DNA-Analysen zeigten. Die Untersuchung von Darmlymphknoten ergab, dass sich bei den Mäusen mit den „menschlichen" Darmkeimen genauso wenige Immunzellen entwickelt hatten wie bei Mäusen, deren Darm völlig keimfrei blieb. „Es schien so, als ob diese Mäuse die Bakterien gar nicht erkennen würden", sagt Hachung Chung, ein Mitglied des Forscherteams"

IOS Press serves the information needs of scientific and medical communities worldwide. See what's new and browse our books and journals to learn more.

Welcome to the future! Here you will find a speculative timeline of future history. Part fact and part fiction, the timeline is based on detailed research that includes analysis of current trends, projected long-term environmental changes, advances in technology such as Moore's Law, future medical breakthroughs, and the evolving geopolitical landscape. Where possible, references have been provided to support the predictions. FutureTimeline.net is intended to be an ongoing, collaborative project that is open for discussion - we welcome ideas from scientists, futurists, inventors, writers and anyone else interested in the future of our world.

iAMscientist is a global community of science, technology and medical researchers who come together to accelerate research, support career development and drive the distribution of discoveries.

Pillbox enables rapid identification of unknown solid-dosage medications (tablets/capsules) based on physical characteristics and high-resolution images.

"Cellendes continously expands the 3-D Life product line to provide an innovative and increasingly comprehensive technology for a broad range of applications in 3-D cell culture. Cellendes seeks collaborations with academic and industrial partners to explore and develop the use of the 3-D Life technology in complex cell-based assays and tissue models for drug screening as well as in biomedical engineering. Cellendes was founded in 2009 by Dr. Brigitte Angres and Dr. Helmut Wurst. Cellendes is a spinoff company of the NMI Natural and Medical Sciences Institute at the University of Tübingen."

Creative Bioarray provides various human and animal cell lines that are invaluable for medical, scientific and pharmaceutical institutions. Creative Bioarray offers Oral Tumor Cells for your research.

Creative Bioarray provides various human and animal cell lines that are invaluable for medical, scientific and pharmaceutical institutions. Creative Bioarray offers Kidney Tumor Cells for your research.

Creative Bioarray provides various human and animal cell lines that are invaluable for medical, scientific and pharmaceutical institutions. Creative Bioarray offers Ovarian Tumor Cells for your research.

Creative Bioarray provides various human and animal cell lines that are invaluable for medical, scientific and pharmaceutical institutions. Creative Bioarray offers Mouse Embryonic Stem Cells for your research.

Creative Bioarray provides various human and animal cell lines that are invaluable for medical, scientific and pharmaceutical institutions. Creative Bioarray offers Testicular Tumor Cells for your research.

Creative Bioarray provides various human and animal cell lines that are invaluable for medical, scientific and pharmaceutical institutions. Creative Bioarray offers Adult Stem Cells for your research.